id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-1967-0005,FDA,FDA-2018-N-1967,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; Biosimilars User Fee Program",Notice,30 Day Proposed Information Collection,2021-12-22T05:00:00Z,2021,12,2021-12-22T05:00:00Z,2022-01-22T04:59:59Z,2021-12-22T13:37:54Z,2021-27680,0,0,0900006484ee0c68
FDA-2018-N-1967-0004,FDA,FDA-2018-N-1967,Agency Information Collection Activities; Proposed Collection; Comment Request; Biosimilars User Fee Program,Notice,60 Day Proposed Information Collection,2021-09-17T04:00:00Z,2021,9,2021-09-17T04:00:00Z,2021-11-17T04:59:59Z,2021-09-23T19:25:25Z,2021-20060,0,0,0900006484d8c256